Inside informationEnglish
Press Release: Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 08/06/2026, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 116336_20260608